SGMT SCHEDULE 13G: SEC filing
Filed with the SEC on · accession 0001831942-26-000045
SGMT filed a SCHEDULE 13G (schedule 13g) with the SEC on Oct 7, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +1.4% by the first close after the filing.
Summary of the filing
Commodore Capital LP, Commodore Capital Master LP, Robert Egen Atkinson, and Michael Kramarz filed a joint filing agreement as part of a Schedule 13G disclosing their passive ownership position in Sagimet Biosciences Inc.
Key details
How SGMT stock reacted
Close before
$8.76
Oct 6, 2026
First close after
+1.37%
$8.88
5 trading days
-8.90%
$7.98
Since filing
+12.44%
$9.85
✦ Ask GOAX AI about this filing — what it means for SGMT, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SGMT?
Click hereFrequently asked questions
What did SGMT file with the SEC on Oct 7, 2026?
SGMT filed a SCHEDULE 13G (SEC filing). Commodore Capital LP, Commodore Capital Master LP, Robert Egen Atkinson, and Michael Kramarz filed a joint filing agreement as part of a Schedule 13G disclosing their passive ownership position in Sagimet Biosciences Inc.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did SGMT stock react to this filing?
SGMT closed at $8.76 before the filing and $8.88 on Oct 7, 2026 (+1.37%). Five trading days later: $7.98 (-8.90%).
Other SGMT SEC filings
- 8-K · SEC filingOct 22, 2026
- 8-K · Secondary offeringOct 1, 2026
- 8-K · Fda approvalSep 30, 2026
- 424B3 · Secondary offeringSep 30, 2026
- 8-K · Fda approvalAug 13, 2026
- 8-K · SEC filingAug 11, 2026
- 10-Q · SEC filingAug 11, 2026
- 8-K · SEC filingJul 21, 2026
- 8-K · SEC filingJun 12, 2026
- 8-K · SEC filingJun 3, 2026
Get alerts when SGMT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days